Efficacité du vaccin pneumococcique heptavalent conjugué (Prevenar®) contre les infections invasives à pneumocoque : bénéfice attendu pour les enfants en France
- 31 July 2004
- journal article
- abstracts
- Published by Elsevier in Archives de Pédiatrie
- Vol. 11 (7), 843-853
- https://doi.org/10.1016/j.arcped.2004.03.126
Abstract
No abstract availableKeywords
This publication has 31 references indexed in Scilit:
- Epidemiology of pneumococcal infections in Swedish childrenActa Paediatrica, 2007
- Prediction of the potential benefit of different pneumococcal conjugate vaccines on invasive pneumococcal disease in German childrenThe Pediatric Infectious Disease Journal, 2002
- Epidemiology of Invasive Streptococcus pneumoniae Infections in Children in Spain, 1996–1998Journal of Infection, 2002
- The epidemiology of invasive Streptococcus pneumoniae disease in Catalonia (Spain)A hospital-based studyVaccine, 2002
- The Changing Epidemiology of Bacterial Meningitis and Invasive Non-meningitic Bacterial Disease in Scotland During the Period 1983-99Scandinavian Journal of Infectious Diseases, 2002
- Postlicensure evaluation of the effectiveness of seven valent pneumococcal conjugate vaccineThe Pediatric Infectious Disease Journal, 2001
- Invasive Pneumococcal Disease in England and Wales: Vaccination ImplicationsThe Journal of Infectious Diseases, 2001
- Policy Statement: Recommendations for the Prevention of Pneumococcal Infections, Including the Use of Pneumococcal Conjugate Vaccine (Prevnar), Pneumococcal Polysaccharide Vaccine, and Antibiotic ProphylaxisPublished by American Academy of Pediatrics (AAP) ,2000
- Efficacy, safety and immunogenicity of heptavalent pneumococcal conjugate vaccine in childrenThe Pediatric Infectious Disease Journal, 2000
- Safety and immunogenicity of heptavalent pneumococcal CRM197 conjugate vaccine in infants and toddlersThe Pediatric Infectious Disease Journal, 1999